Cargando…
Therapeutic strategies for COVID-19: progress and lessons learned
The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous efforts to develop therapeutic strategies that target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and/or human proteins to control viral infection, encompassing hundreds of potential drugs and thousands of pa...
Autores principales: | Li, Guangdi, Hilgenfeld, Rolf, Whitley, Richard, De Clercq, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113999/ https://www.ncbi.nlm.nih.gov/pubmed/37076602 http://dx.doi.org/10.1038/s41573-023-00672-y |
Ejemplares similares
-
Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf
por: De Clercq, Erik, et al.
Publicado: (2023) -
Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective
por: Miao, Miao, et al.
Publicado: (2021) -
Towards Efficient and Accurate SARS-CoV-2 Genome Sequence Typing Based on Supervised Learning Approaches
por: Miao, Miao, et al.
Publicado: (2022) -
Approved HIV reverse transcriptase inhibitors in the past decade
por: Li, Guangdi, et al.
Publicado: (2022) -
Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy
por: Miao, Miao, et al.
Publicado: (2020)